The groundbreaking experiment in Valence, Spain offers hope for cancer patients while also reducing the side effects of chemotherapy and radiotherapy. Laura, a trained doctor, was diagnosed with stage 3 breast cancer. After three surgeries, chemotherapy, and radiotherapy, she continues to undergo hormonal and experimental treatment. Pedro, a lung cancer survivor, still suffers from severe side effects. He describes the lasting impact of his treatments, such as loss of touch sensation and a constant sunburn-like feeling.
Researchers in the European project Ulises are working on a treatment using nanoparticle technology that could potentially help cancer patients like Laura and survivors like Pedro. Initially tested against pancreatic cancer, this project aims to trigger the body’s rejection of tumors, similar to a “vaccine effect.” By introducing specific molecules into the tumor, the immune response is activated, explains Cristina Fillat, the project coordinator.
Genetic material delivery to tumor cells is crucial, with the assistance of nanoparticles similar to those used in anti-Covid-19 vaccines. If successful against pancreatic cancer, this vaccine could open up new therapeutic opportunities for other currently incurable and deadly tumors, according to José Antonio López-Guerrero, head of the Molecular Biology Laboratory in Valence.
This potential treatment would mark a significant milestone in the field of science and research, as it specifically targets tumor cells, reducing the side effects associated with current treatments like chemotherapy and radiotherapy. The impact of this innovative approach could revolutionize cancer treatment and improve the quality of life for patients worldwide.